PLAY PODCASTS
Ep. 72: Outcome of neurological toxicities of immune checkpoint inhibitors and the effect of drug rechallenge

Ep. 72: Outcome of neurological toxicities of immune checkpoint inhibitors and the effect of drug rechallenge

Moderator: Yildiz Değirmenci (Istanbul, Turkey) Guest: Antonio Farina (Florence, Italy) This week, Dr. Yildiz Değirmenci and Dr. Antonio Farina discuss life-threatening neurological toxicities from immune checkpoint inhibitors. Dr. Farina highlights hig

eanCast: Weekly Neurology

November 26, 202314m 55s

Audio is streamed directly from the publisher (audio.podigee-cdn.net) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Moderator: Yildiz Değirmenci (Istanbul, Turkey) Guest: Antonio Farina (Florence, Italy) This week, Dr. Yildiz Değirmenci and Dr. Antonio Farina discuss life-threatening neurological toxicities from immune checkpoint inhibitors. Dr. Farina highlights hig

Moderator: Yildiz Değirmenci (Istanbul, Turkey)

Guest: Antonio Farina (Florence, Italy)

This week, Dr. Yildiz Değirmenci and Dr. Antonio Farina discuss life-threatening neurological toxicities from immune checkpoint inhibitors. Dr. Farina highlights high fatality rates, long-term disabilities, and the urgency of early recognition and treatment. The episodeexplores management, including discontinuation and corticosteroids, and factors influencing outcomes. It touches on the association between adverse events and treatment response, resuming inhibitors, and stresses a multidisciplinary approach for informed decision-making. The conclusion emphasizes the importance of neurologists' awareness in addressing these rare yet significant neurological complications.